3 Monster Dividend Stocks to Hold for the Next 10 Years

Source Motley_fool

Key Points

  • Clorox's Purell acquisition strengthens long-term growth while supporting a nearly 5% dividend yield.

  • Brown-Forman's iconic spirits portfolio and 42-year dividend streak reward patient investors.

  • Kimberly-Clark's transformation and trusted brands position it for steady decade-long compounding.

  • 10 stocks we like better than Kimberly-Clark ›

Ten years is a long time. In a decade, interest rates will have cycled multiple times, a recession will have come and gone, and the stocks that dominate the headlines today will likely have been replaced by something no one is talking about yet. That's exactly why dividend investing across a 10-year window is different from everything else in a portfolio.

You're not really trying to predict the next quarter or the next runner. You're buying businesses that will pay you while you wait, and ideally pay you more each year than they did the year before. The three companies below are solid dividend stocks to hold for the next 10 years.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »

1. The Clorox Company

The Clorox Company (NYSE: CLX) has been through a stretch that would have broken a lesser brand. A $580 million ERP system upgrade in 2023 caused a cyberattack disruption that knocked organic sales down 17% in a single quarter. The stock fell to decade-low valuations. Most investors moved on.

An individual washes their hands in a sink.

Image source: Getty Images.

What happened next is the actual story. Clorox spent the following years rebuilding, and in January 2026, it made its most significant strategic move in decades: a $2.25 billion acquisition of GOJO Industries, the maker of Purell. The deal closed April 1, 2026. Purell is not a specialty brand. It is the category. After the pandemic permanently changed how the world thinks about hand hygiene, owning Purell for the next 10 years means owning a product that now lives in every school, hospital, office building, and restaurant in the country, as a reflex rather than a purchase decision. Clorox's long-term sales target of 3% to 5% organic growth now has a new engine behind it.

The near-term noise is real: Fiscal 2026 earnings-per-share guidance was cut as GOJO integration costs and debt weighed on the balance sheet. The stock yields nearly 5% at current prices. Morningstar values it at $134 per share against a price near $95. For a 10-year holder, those integration costs become a footnote. The Purell brand does not.

2. Brown-Forman Corporation

Brown-Forman Corporation (NYSE: BFB) has raised its dividend for 42 consecutive years. That streak covers the dot-com crash, the 2008 financial crisis, COVID-19, and the current macro uncertainty, and it kept going through all of it. The company makes Jack Daniel's, Woodford Reserve, Herradura Tequila, and el Jimador, among others. Its core product is aged whiskey, which takes years to produce, creates a natural supply constraint, and carries margin profiles that most consumer goods companies would trade anything to have.

The stock is under pressure right now because the global spirits market has softened. Premium bourbon and tequila consumers pulled back in 2025 and early 2026 as price fatigue set in after years of category inflation. This is all a cyclical problem, not a structural one. Meanwhile, Brown-Forman launched Jack Daniel's Tennessee Blackberry in 2026 and saw "outstanding consumer engagement" on the new flavor extension -- proof that the brand still has room to grow inside an audience it already owns.

The dividend yield near current prices sits around 3.6%. A decade from now, if Brown-Forman maintains its historical dividend growth rate of roughly 6% to 8% per year, the yield on today's cost basis will be substantially higher, which is the entire logic of buying a dividend grower when sentiment is low. Ten years of compounding on a premium spirits portfolio is a quiet but powerful bet.

3. Kimberly-Clark

Kimberly-Clark (NASDAQ: KMB) is in the middle of what its own company filings call the most consequential transformation in its 154-year history. The company that makes Huggies, Kleenex, Scott, Cottonelle, and Pull-Ups is rebuilding itself from the inside -- selling lower-margin businesses, restructuring its cost base, and reinvesting in brand equity and product innovation.

In Q1 2026, adjusted operating profit grew 3.7%, and the company reaffirmed its full-year guidance -- a signal that the restructuring isn't disrupting the underlying business. In May, Pull-Ups launched a new Learning Layer system that adds educational interactivity to the training pant category. That might sound like a small product update, but Kimberly-Clark has been a Dividend King -- notching 50-plus consecutive years of dividend increases -- by making exactly these kinds of moves: incremental improvements to products parents buy on autopilot, over and over, for decades.

The pending combination with Kenvue (NYSE: KVUE) will create one of the world's largest personal care and consumer health platforms. For a 10-year investor, that combination means owning Kleenex, Huggies, Neutrogena, Tylenol, and Listerine under one operational umbrella. The dividend yield is safe, the brands are permanent, and the stock doesn't show up on any "hot picks" list, which is common for 10-year compounders.

Should you buy stock in Kimberly-Clark right now?

Before you buy stock in Kimberly-Clark, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Kimberly-Clark wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $417,305!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,293,148!*

Now, it’s worth noting Stock Advisor’s total average return is 936% — a market-crushing outperformance compared to 209% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of June 21, 2026.

Micah Zimmerman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Kenvue. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Hedera Price Analysis: HBAR defies $50B market dip as Nvidia confirms AI partnershipHedera maintains strength above $0.15, signaling investor confidence as NVIDIA’s AI integration boosts long-term bullish sentiment and breakout potential.
Author  FXStreet
Apr 09, 2025
Hedera maintains strength above $0.15, signaling investor confidence as NVIDIA’s AI integration boosts long-term bullish sentiment and breakout potential.
placeholder
Why Mantra token’s dramatic 90% crash wiped out $5.2B market shareMantra (OM) price hovered at $0.83 during the Asian session on Monday, following a massive 90% crash from $6.33 on Sunday. The crash wiped out $5.2 billion in the token’s market capitalization, quickly drawing comparisons to the infamous collapse of Terra LUNA and FTX in 2022.
Author  FXStreet
Apr 14, 2025
Mantra (OM) price hovered at $0.83 during the Asian session on Monday, following a massive 90% crash from $6.33 on Sunday. The crash wiped out $5.2 billion in the token’s market capitalization, quickly drawing comparisons to the infamous collapse of Terra LUNA and FTX in 2022.
placeholder
Tron’s 374% Profit-Taking Spree Uncovered—Here’s Who Was Behind ItOn-chain data shows Tron (TRX) observed a large profit-taking spike earlier in the month. Which type of holder was responsible for the move? Tron SOPR Saw A Huge Spike Earlier In The Month In a
Author  NewsBTC
Jun 25, 2025
On-chain data shows Tron (TRX) observed a large profit-taking spike earlier in the month. Which type of holder was responsible for the move? Tron SOPR Saw A Huge Spike Earlier In The Month In a
placeholder
OpenAI Considers Funding Brain Implant Startup to Challenge Musk’s Neuralink – ReportsOpenAI and its co-founder Sam Altman are preparing to back a new startup aiming to rival Elon Musk’s Neuralink in the development of brain-computer interface (BCI) technology, multiple sources revealed on Tuesday.
Author  Mitrade
Aug 13, 2025
OpenAI and its co-founder Sam Altman are preparing to back a new startup aiming to rival Elon Musk’s Neuralink in the development of brain-computer interface (BCI) technology, multiple sources revealed on Tuesday.
placeholder
Tom Lee’s BitMine Adds Another $42 Million in Ethereum Despite Crypto WinterBitMine, the largest corporate holder of Ethereum, has capitalized on the digital asset’s recent price volatility to expand its treasury holdings.On February 7, blockchain analysis platform Lookonchai
Author  Beincrypto
Feb 09, Mon
BitMine, the largest corporate holder of Ethereum, has capitalized on the digital asset’s recent price volatility to expand its treasury holdings.On February 7, blockchain analysis platform Lookonchai
goTop
quote